Andrea Torchia

机构：National Cancer Institute, Tumori Foundation, Fondazione IRCCS Istituto Nazionale dei Tumori, Sapienza University of Rome · ORCID：0000-0002-4020-6893

发表论文 20 篇 · 总被引 86 次 · h-index 5

代表论文

• Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials (2023 · Critical Reviews in Oncology/Hematology · 被引 35)
• KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma (2023 · Lung Cancer · 被引 13)
• Clinical implications of the Drug-Drug Interaction in Cancer Patients treated with innovative oncological treatments (2024 · Critical Reviews in Oncology/Hematology · 被引 11)
• PARP inhibitor‐based treatment in metastatic, castration‐resistant prostate cancer (mCRPC): A systematic review and meta‐analysis (2025 · BJUI Compass · 被引 6)
• Duration of humoral response to the third dose of BNT162b2 vaccine in patients with solid cancer: Is fourth dose urgently needed? (2022 · European Journal of Cancer · 被引 6)
• Antibody-Based Therapeutics in Small Cell Lung Cancer: A Narrative Review (2025 · Biologics · 被引 4)